Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3912]

Daratumumab plus bortezomib/lenalidomide/dexamethasone in transplant-eligible...

Dr Paula Rodríguez-Otero - Clinica Universidad de Navarra, Pamplona, Spain

Daratumumab plus bortezomib/lenalidomide/dexamethasone in transplant-eligible patients with NDMM: MRD analysis ( Dr Paula Rodríguez-Otero - Clinica Universidad de Navarra, Pamplona, Spain )

Melanoma outcomes improved by dual immunotherapy before surgery rather than...

Prof Christian Blank - Netherlands Cancer Institute, Amsterdam, Netherlands

Melanoma outcomes improved by dual immunotherapy before surgery rather than after ( Prof Christian Blank - Netherlands Cancer Institute, Amsterdam, Netherlands )

Addition of cabazitaxel to abiraterone/prednisone significantly prolonged PFS...

Dr Christos Kyriakopoulos - University of Wisconsin Carbone Cancer Center...

Addition of cabazitaxel to abiraterone/prednisone significantly prolonged PFS in extensive mCRPC following docetaxel ( Dr Christos Kyriakopoulos - University of Wisconsin Carbone Cancer Center, Madison, USA )

Atezolizumab versus placebo in combination with bevacizumab and non-platinum...

Prof Frederik Marmé - Heidelberg University, Heidelberg, Germany

Atezolizumab versus placebo in combination with bevacizumab and non-platinum-based chemotherapy in recurrent ovarian cancer ( Prof Frederik Marmé - Heidelberg University, Heidelberg, Germany )

Some advanced epithelial ovarian cancer patients can avoid a lymphadenectomy...

Prof Jean-Marc Classe - Nantes Université, Nantes, France

Some advanced epithelial ovarian cancer patients can avoid a lymphadenectomy without impacting survival outcomes ( Prof Jean-Marc Classe - Nantes Université, Nantes, France )

Neoadjuvant daromun effective and safe for resectable, locally advanced melanoma

Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany

Neoadjuvant daromun effective and safe for resectable, locally advanced melanoma ( Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany )

Looking at real world evidence on PSA testing in prostate cancer

Dr Friederike Schlurmann, Prof Boris Hadaschik and Prof Karim Fizazi

Looking at real world evidence on PSA testing in prostate cancer ( Dr Friederike Schlurmann, Prof Boris Hadaschik and Prof Karim Fizazi )

Telehealth delivery of palliative care an effective alternative to in-person...

Dr Joseph Greer - Harvard Medical School, Boston, USA

Telehealth delivery of palliative care an effective alternative to in-person visits for patients with advanced lung cancer ( Dr Joseph Greer - Harvard Medical School, Boston, USA )

Ciltacabtagene autoleucel benefit for lenalidomide-refractory FHR multiple...

Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA

$Ciltacabtagene autoleucel benefit for lenalidomide-refractory FHR multiple myeloma ( Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA )$

Immunotherapy promise for gynaecologic extra-renal clear cell carcinomas

Prof Don Dizon - Lifespan Cancer Institute, Providence, USA

Immunotherapy promise for gynaecologic extra-renal clear cell carcinomas ( Prof Don Dizon - Lifespan Cancer Institute, Providence, USA )

Nivolumab plus ipilimumab shows clinical benefit as first-line treatment for...

Prof Heinz-Josef Lenz - Keck School of Medicine of USC, Los Angeles, USA

Nivolumab plus ipilimumab shows clinical benefit as first-line treatment for centrally confirmed MSI-H/dMMR mCRC ( Prof Heinz-Josef Lenz - Keck School of Medicine of USC, Los Angeles, USA )

Ivonescimab benefit for EGFR mutant NSCLC patients who failed TKI therapy

Prof Li Zhang - Sun Yat-Sen University Cancer Center, Guangzhou, China

Ivonescimab benefit for EGFR mutant NSCLC patients who failed TKI therapy ( Prof Li Zhang - Sun Yat-Sen University Cancer Center, Guangzhou, China )

More from ecancer